Regulation of alphaIIb beta3 function in human B lymphocytes

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• The platelet integrin alphaIIb beta3 plays a crucial role in cell adhesion and aggregation.
• Understanding integrin activation mechanisms in non-platelet cells, like B lymphocytes, is important for immune function research.

Purpose of the Study:

• To investigate the activation of integrin alphaIIb beta3 in a B lymphocyte model.
• To determine if a G protein-coupled receptor can activate alphaIIb beta3 in lymphocytes.
• To elucidate the signaling pathway involved in alphaIIb beta3 activation in B cells.

Main Methods:

• Coexpression of human formyl peptide receptor (fPR) and alphaIIb beta3 in B lymphocytes.
• Stimulation with phorbol myristate acetate (PMA) and the fPR agonist formyl Met-Leu-Phe (fMLP).
• Assessment of lymphocyte adherence to fibrinogen and fibrinogen binding using various inhibitors (pertussis toxin, bisindolylmaleimide I, genistein, piceatannol, C3 exoenzyme, cytochalasin D).

Main Results:

• fMLP stimulation induced lymphocyte adherence to fibrinogen and soluble fibrinogen binding.
• Pertussis toxin-sensitive pathway indicated G-protein alpha-i (Galphai) involvement in fMLP response.
• Protein kinase C inhibition affected both fMLP and PMA responses.
• Tyrosine kinase and RhoA inhibitors had no effect on alphaIIb beta3 activation.
• Cytochalasin D showed differential effects on PMA-stimulated and unstimulated cells.

Conclusions:

• Integrin alphaIIb beta3 in B lymphocytes can be activated by a physiologic agonist via the fPR.
• The activation pathway involves Galphai, protein kinase C, and the actin cytoskeleton.
• This study provides insights into integrin signaling in B lymphocytes.